检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

793 Combined administration of the dual A2aR/A2bR antagonist etrumadenant with a reduced chemotherapy regimen leads to enhanced tumor efficacy and survival

Sachie Marubayashi,Dana Piovesan,Ferdie Soriano, Gonzalo Barajas, Ruben Flores, Janine Kline,Matthew J. Walters,Daniel DiRenzo

Regular and Young Investigator Award Abstracts（2023）

引用 0|浏览3
暂无评分
关键词
reduced chemotherapy regimen,chemotherapy regimen,tumor efficacy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要